Abstract:Magnetic Resonance Imaging(MRI)is a powerful method for clinical diagnosis and therapy due to the distinguishing characteristics of providing high-quality three-dimensional images of soft tissue without the need for harmful ionizing radiation.Complexes of gadolinium(Ⅲ)have proven to be especially effective M RI contrast agents,as it is estimated that they are needed for over 30% of the patients to accelerate relaxation rate of in vivo water protons,thus enhancing the contrast of different biological tissues and definition between normal tissues and diseased parts.For more sensitive small-molecule gadolinium-based M RI contrast agents,one essential requirement is to increase the hydration number q, which enhances the gadolinium's relaxivity.However,with the concern of chronic kidney disease(CKD) and nephrogenic systemic fibrosis(NSF),competition between strong chelate stability and free water coordination sites has increasingly become a challenge to M RI enhancement agent design.A highly stable N-oxide-DTPA-bisamide-based Gd(Ⅲ)complex with 3 coordinated water molecules is synthesized.The general methods such as 1 H-NMR,13C-NMR and ESI-MS spectroscopy are used to characterize the structures of the ligand and the complex.T he hydration number determined by the fluorescence lifetime of its Europium(Ⅲ)analogue is 3.M RI measurement show s much higher relaxivity value(16.39 mM -1·s-1) than commercial contrast agents.By fitting the potentiometric data with HYPERQUAD program,the formation constants of the Gd(Ⅲ)complex are calculated and demonstrated a superior stability over Gd-DTPA-BMA(Omniscan?).Meanwhile,in vivo imaging shows good imaging quality and cell tests reveal low cytotoxicity of the complexes,which indicate its great potential for future clinical applications.

Gadolinium(III) Chelated Conjugated Polymer As a Potential MRI Contrast Agent

Gadolinium(III) Complex-Backboned Branched Polymers As Imaging Probes for Contrast-Enhanced Magnetic Resonance Angiography

A conjugated polymer-Gd (III) complex as pH sensitive contrast agent in magnetic resonance imaging

An MRI contrast agent based on a zwitterionic metal-chelating polymer for hepatorenal angiography and tumor imaging.

A new biodegradable and biocompatible gadolinium (III) -polymer for liver magnetic resonance imaging contrast agent

A Biocompatible Gadolinium-Based Amino Acid Copolymer Contrast Agent for Magnetic Resonance Imaging

Safe and Potent MRI Contrast Agents by Complexing Gadolinium with Enzyme/reduction Dual-Sensitive Branched Polymers

The gadolinium complexes with polyoxometalates as potential MRI contrast agents.

Facile Preparation of a New Gadofullerene-Based Magnetic Resonance Imaging Contrast Agent with High 1H Relaxivity

Linear and Core-Crosslinked Glycopolymer-Gadolinium Conjugates: Preparation and Their Behaviors as Nanoscale Magnetic Resonance Imaging Contrast Agents.

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Block Copolymer-Based Gadolinium Nanoparticles As MRI Contrast Agents with High T1 Relaxivity

Facile preparation of gadolinium(III) chelates functionalized carbon quantum dot-based contrast agent for magnetic resonance/fluorescence multimodal imaging

Gadolinium(III)-based Polymeric Magnetic Resonance Imaging Agents for Tumor Imaging

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

The research progress of gadolinium(iii)-based macromolecular mri contrast agents

Preparation and performance of biocompatible gadolinium polymer as liver-targeting magnetic resonance imaging contrast agent

Gadolinium-1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate of arabinogalactan as a potential liver-targeting magnetic resonance imaging contrast agent.